The previous page is sending you to https://www.prnewswire.com/news-releases/fda-approves-new-indication-for-drug-containing-an-active-ingredient-derived-from-cannabis-to-treat-seizures-in-rare-genetic-disease-301104233.html.

 If you do not want to visit that page, you can return to the previous page.